PathAI Engager | In-Person Event

PathAI

Thursday, November 3 | Washington DC | 6.00pm ET

Please Note: This event is taking place in-person only, and online attendance will not be available.

Accelerating NASH Drug Development with AI-Powered NASH Pathology

The PathAI Engager is an exclusive event designed to navigate through the latest advancements in AI-powered NASH assessment and discover how biopharma companies are taking this approach in their clinical trials for more reproducible results, as well as unlocking novel insights in translational research.

Uniting industry experts dedicated to accelerating the frontier of therapeutic development in NASH, this is your opportunity to address the most immediate challenges with variability in NASH-CRN scoring for enrollment and endpoints in NASH drug development today.

Exclusively designed for NASH biopharma leaders working in the clinical development space, you can expect:

  • Learning how to overcome trial delays due to challenging patient enrollment and additional costs due to inconsistent performance of pathology operations
  • Addressing variability in biopsy sampling by identifying new features and measure which may be more representative of overall disease activity and drug efficacy, and identifying what this could mean for the future of NASH drug development
  • Discovering how PathAI's AI-powered histologic measurement of NASH provides reproducible endpoint analysis and patient enrollment across the clinical development pipeline

 

Join us for an insightful panel discussion over complimentary appetizers and drinks and gain greater confidence in your NASH drug development program

Expert Speakers Include:

Andy Beck, MD, PhD

Chief Executive Officer & Co-Founder

PathAI

Anne-Sophie Sejling, MD, PhD

Medical Director

Novo Nordisk

Cathy O’Hare, PhD

Medicine Development Leader-NASH

GSK

Eric Walk, MD

Chief Medical Officer

PathAI

Sophie Jeannin Megnien, MD

Chief Medical Officer

Summit Clinical Research

Panelists are participating as individuals and not as representatives of their respective companies.

Register Your Place By Filling Out the Form:

Please Note: This event is taking place in-person only, and online attendance will not be available.

This event is reserved for decision makers and senior representatives in the biopharma community with therapies in their pipeline. By registering online, you are submitting your interest in this exclusive networking meeting, and a colleague will be in touch upon registering to confirm or decline your place based on the mentioned criteria.

Agenda:

6:00 pm Registration & Welcome Reception

6:30 pm Opening Remarks & Introduction

6:35 pm Panel Discussion & Q&A: Using AI-Powered NASH Pathology to Accelerate NASH Drug Development: Where Are We Today & Where Are We Headed?

Synopsis

  • Discussing latest advancements of AI-powered pathology to address the most immediate issues with variability in CRN scoring for enrollment and endpoints to advance NASH drug development
  • Tackling numerous challenges that impact trial success including inter-reader variability from manual reads, trial delays due to challenging patient enrollment, and additional costs or delays due to inconsistent performance of pathology operations
  • Discovering how PathAI’s AI-powered measurement of NASH provides reproductible endpoint analysis and patient enrollment across the clinical development pipeline

7:15 pm Networking Session

Synopsis

This is an informal and exclusive networking opportunity for you to engage with biopharma leaders and PathAI to discuss AI-Powered NASH drug development!

8:00 pm Closing Remarks & End of PathAI Engager

Venue:

Stilla AACR Engager

About PathAI

PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine.

www.pathai.com